BOSTON SCIENTIFIC CORP (BSX.DE) Stock Fundamental Analysis
FRA:BSX - Deutsche Boerse Ag - US1011371077 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to BSX. BSX was compared to 57 industry peers in the Health Care Equipment & Supplies industry. BSX scores excellent on profitability, but there are some minor concerns on its financial health. BSX shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
BSX had positive earnings in the past year.
In the past year BSX had a positive cash flow from operations.
BSX had positive earnings in 4 of the past 5 years.
BSX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.06%, BSX is in the better half of the industry, outperforming 71.93% of the companies in the same industry.
With a decent Return On Equity value of 9.15%, BSX is doing good in the industry, outperforming 68.42% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.57%, BSX is doing good in the industry, outperforming 71.93% of the companies in the same industry.
BSX had an Average Return On Invested Capital over the past 3 years of 6.54%. This is in line with the industry average of 8.12%.
The 3 year average ROIC (6.54%) for BSX is below the current ROIC(7.57%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.06% | ||
| ROE | 9.15% | ||
| ROIC | 7.57% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.54%
ROIC(5y)5.68%
1.3 Margins
The Profit Margin of BSX (11.58%) is better than 77.19% of its industry peers.
In the last couple of years the Profit Margin of BSX has declined.
The Operating Margin of BSX (18.78%) is better than 82.46% of its industry peers.
In the last couple of years the Operating Margin of BSX has remained more or less at the same level.
The Gross Margin of BSX (68.65%) is better than 77.19% of its industry peers.
In the last couple of years the Gross Margin of BSX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.78% | ||
| PM (TTM) | 11.58% | ||
| GM | 68.65% |
OM growth 3Y0.33%
OM growth 5Y1.13%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.3%
GM growth 5Y-0.65%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BSX is destroying value.
BSX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BSX has been increased compared to 5 years ago.
The debt/assets ratio for BSX is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.04 indicates that BSX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.04, BSX belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
The Debt to FCF ratio of BSX is 3.75, which is a good value as it means it would take BSX, 3.75 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.75, BSX is in the better half of the industry, outperforming 75.44% of the companies in the same industry.
A Debt/Equity ratio of 0.47 indicates that BSX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.47, BSX is in line with its industry, outperforming 47.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.75 | ||
| Altman-Z | 6.04 |
ROIC/WACC0.88
WACC8.58%
2.3 Liquidity
A Current Ratio of 1.45 indicates that BSX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.45, BSX is in line with its industry, outperforming 40.35% of the companies in the same industry.
A Quick Ratio of 0.88 indicates that BSX may have some problems paying its short term obligations.
With a Quick ratio value of 0.88, BSX is not doing good in the industry: 64.91% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.45 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
BSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.17%, which is quite impressive.
BSX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.56% yearly.
Looking at the last year, BSX shows a quite strong growth in Revenue. The Revenue has grown by 19.35% in the last year.
BSX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.30% yearly.
EPS 1Y (TTM)26.17%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%33.93%
Revenue 1Y (TTM)19.35%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%20.93%
3.2 Future
BSX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.43% yearly.
BSX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.66% yearly.
EPS Next Y17.44%
EPS Next 2Y15.26%
EPS Next 3Y14.33%
EPS Next 5Y12.43%
Revenue Next Year17.34%
Revenue Next 2Y13.99%
Revenue Next 3Y12.68%
Revenue Next 5Y10.66%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
BSX is valuated quite expensively with a Price/Earnings ratio of 38.79.
The rest of the industry has a similar Price/Earnings ratio as BSX.
BSX's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.19.
A Price/Forward Earnings ratio of 31.41 indicates a quite expensive valuation of BSX.
BSX's Price/Forward Earnings is on the same level as the industry average.
BSX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 35.33, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.79 | ||
| Fwd PE | 31.41 |
4.2 Price Multiples
BSX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BSX is more expensive than 63.16% of the companies in the same industry.
BSX's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.41 | ||
| EV/EBITDA | 35.87 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BSX does not grow enough to justify the current Price/Earnings ratio.
BSX has a very decent profitability rating, which may justify a higher PE ratio.
BSX's earnings are expected to grow with 14.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.22
PEG (5Y)4.06
EPS Next 2Y15.26%
EPS Next 3Y14.33%
5. Dividend
5.1 Amount
BSX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BSX (7/15/2025, 7:00:00 PM)
89.6
+0.6 (+0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners93.03%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap132.56B
Analysts84.62
Price Target105.35 (17.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.08%
Min EPS beat(2)5.6%
Max EPS beat(2)10.56%
EPS beat(4)4
Avg EPS beat(4)7.06%
Min EPS beat(4)5.6%
Max EPS beat(4)10.56%
EPS beat(8)8
Avg EPS beat(8)6.71%
EPS beat(12)11
Avg EPS beat(12)5.15%
EPS beat(16)15
Avg EPS beat(16)4.51%
Revenue beat(2)2
Avg Revenue beat(2)1.51%
Min Revenue beat(2)0.97%
Max Revenue beat(2)2.04%
Revenue beat(4)4
Avg Revenue beat(4)1.92%
Min Revenue beat(4)0.97%
Max Revenue beat(4)3.16%
Revenue beat(8)8
Avg Revenue beat(8)2.02%
Revenue beat(12)10
Avg Revenue beat(12)1.79%
Revenue beat(16)12
Avg Revenue beat(16)1.49%
PT rev (1m)0.06%
PT rev (3m)-4.54%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)2.46%
EPS NY rev (1m)0.15%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)2.4%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.79 | ||
| Fwd PE | 31.41 | ||
| P/S | 8.83 | ||
| P/FCF | 51.41 | ||
| P/OCF | 40.65 | ||
| P/B | 6.98 | ||
| P/tB | N/A | ||
| EV/EBITDA | 35.87 |
EPS(TTM)2.31
EY2.58%
EPS(NY)2.85
Fwd EY3.18%
FCF(TTM)1.74
FCFY1.95%
OCF(TTM)2.2
OCFY2.46%
SpS10.15
BVpS12.84
TBVpS-0.98
PEG (NY)2.22
PEG (5Y)4.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.06% | ||
| ROE | 9.15% | ||
| ROCE | 9.4% | ||
| ROIC | 7.57% | ||
| ROICexc | 7.73% | ||
| ROICexgc | 25.4% | ||
| OM | 18.78% | ||
| PM (TTM) | 11.58% | ||
| GM | 68.65% | ||
| FCFM | 17.17% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.54%
ROIC(5y)5.68%
ROICexc(3y)6.7%
ROICexc(5y)5.9%
ROICexgc(3y)22.68%
ROICexgc(5y)19.43%
ROCE(3y)8.12%
ROCE(5y)7.05%
ROICexcg growth 3Y8.56%
ROICexcg growth 5Y6.81%
ROICexc growth 3Y4.36%
ROICexc growth 5Y5.23%
OM growth 3Y0.33%
OM growth 5Y1.13%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.3%
GM growth 5Y-0.65%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.75 | ||
| Debt/EBITDA | 2.3 | ||
| Cap/Depr | 61.86% | ||
| Cap/Sales | 4.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.12% | ||
| Profit Quality | 148.25% | ||
| Current Ratio | 1.45 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z | 6.04 |
F-Score5
WACC8.58%
ROIC/WACC0.88
Cap/Depr(3y)57.82%
Cap/Depr(5y)54.13%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.85%
Profit Quality(3y)134.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.17%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%33.93%
EPS Next Y17.44%
EPS Next 2Y15.26%
EPS Next 3Y14.33%
EPS Next 5Y12.43%
Revenue 1Y (TTM)19.35%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%20.93%
Revenue Next Year17.34%
Revenue Next 2Y13.99%
Revenue Next 3Y12.68%
Revenue Next 5Y10.66%
EBIT growth 1Y30.17%
EBIT growth 3Y12.47%
EBIT growth 5Y10.54%
EBIT Next Year32.67%
EBIT Next 3Y19.08%
EBIT Next 5Y13.71%
FCF growth 1Y151.8%
FCF growth 3Y26.15%
FCF growth 5Y16.61%
OCF growth 1Y114.76%
OCF growth 3Y22.44%
OCF growth 5Y13.34%